Transderm-Scop en es it fr

Transderm-Scop Brand names, Transderm-Scop Analogs

Transderm-Scop Brand Names Mixture

  • No information avaliable

Transderm-Scop Chemical_Formula

C17H21NO4

Transderm-Scop RX_link

No information avaliable

Transderm-Scop fda sheet

Transderm-Scop msds (material safety sheet)

Transderm-Scop Synthesis Reference

No information avaliable

Transderm-Scop Molecular Weight

303.353 g/mol

Transderm-Scop Melting Point

No information avaliable

Transderm-Scop H2O Solubility

No information avaliable

Transderm-Scop State

Solid

Transderm-Scop LogP

1.659

Transderm-Scop Dosage Forms

Liquid

Transderm-Scop Indication

For the treatment of excessive salivation, colicky abdominal pain, bradycardia, sialorrhoea, diverticulitis, irritable bowel syndrome and motion sickness.

Transderm-Scop Pharmacology

Scopolamine is a muscarinic antagonist structurally similar to the neurotransmitter acetylcholine and acts by blocking the muscarinic acetylcholine receptors and is thus classified as an anticholinergic. Scopolamine has many uses including the prevention of motion sickness. It is not clear how Scopolamine prevents nausea and vomiting due to motion sickness. The vestibular part of the ear is very important for balance. When a person becomes disoriented due to motion, the vestibule sends a signal through nerves to the vomiting center in the brain, and vomiting occurs. Acetylcholine is a chemical that nerves use to transmit messages to each other. It is believe that Scopolamine prevents communication between the nerves of the vestibule and the vomiting center in the brain by blocking the action of acetylcholine. Scopolamine also may work directly on the vomiting center. Scopolamine must be taken before the onset of motion sickness to be effective.

Transderm-Scop Absorption

No information avaliable

Transderm-Scop side effects and Toxicity

No information avaliable

Transderm-Scop Patient Information

No information avaliable

Transderm-Scop Organisms Affected

Humans and other mammals